COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Development of an Edible Film - Lined Tetra Pak: Accelerated Shelf Life of Extra Virgin Olive Oil
- Hepatorenal and Cerebral Toxicity Induced by Consumption of Cow Meat Singed with Scrap Tyres: An Experimental Study in a Rat Model
- Abstract Book: 1st International Congress on Sustainable Food Security (SFS) : Innovation and Challenges (2025)
- Mold Chitosan production using Ficus microcarpa fruit
- Farm-to-school nutrition programs with special reference to Egypt and Morocco
- Effect of concentration of Allium cepa and Pimpinella anisum powders on the oxidative stability of oils extracted from peanuts cakes
- Dietary patterns and nutrient intake of pregnant women in Afijio and Oyo East Local Government areas of Oyo State, Nigeria
- Sex and income level can be determinants for meat attachment behavior among Turkish university students
- Translation, Cultural Adaptation, and Validation of the Arabic Version of the STRONGkids Nutrition Screening Tool in the Moroccan Pediatric Clinical Setting
- A Comparative Geochemical Profiling and Physicochemical Classification of Bottle Mineral Waters from Algeria and France: Implications for Consumer Health and Clinical Nutrition
You may also start an advanced similarity search for this article.
NAJFNR is licensed under